Phase II study of irinotecan in combination with capecitabine as a first-line chemotherapy in Asian patients with inoperable hepatocellular carcinoma

  • Tony S.K. Mok*
  • , Tsai Shen Yang
  • , Yee Chao
  • , Cheng Hsu Wang
  • , Mei Ching Liu
  • , Yoon Koo Kang
  • , Won Ki Kang
  • , Jun Suk Kim
  • , Yajie Wang
  • , Thomas Leung
    • *Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Phase II study of irinotecan in combination with capecitabine as a first-line chemotherapy in Asian patients with inoperable hepatocellular carcinoma'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science